The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes of sustained MR4.5 in patients with chronic myeloid leukemia (CML) treated with various tyrosine kinase inhibitors (TKI).
 
Boyu Hu
No Relationships to Disclose
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Farhad Ravandi
Honoraria - Amgen; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amgen; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Merck; Seagen; Sunesis Pharmaceuticals
 
Gautam Borthakur
No Relationships to Disclose
 
Tapan M. Kadia
No Relationships to Disclose
 
Alessandra Ferrajoli
No Relationships to Disclose
 
William G. Wierda
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Naval Guastad Daver
No Relationships to Disclose
 
Naveen Pemmaraju
Honoraria - Incyte; LFB Biotechnologies; Novartis
Consulting or Advisory Role - Incyte; LFB Biotechnologies; Novartis
Research Funding - Incyte; Novartis; Stemline Therapeutics
 
Sara Dellasala
No Relationships to Disclose
 
Sherry Pierce
No Relationships to Disclose
 
Elias Jabbour
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)